MIRA Pharmaceuticals, Inc.
MIRA
$0.78
$0.000.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.11M | 9.41M | 11.03M | 7.54M | 730.50K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 54.30K | 21.70K | 28.10K | 61.90K | 102.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.17M | 9.43M | 11.06M | 7.60M | 832.90K |
|
|
|||||
| Total Current Assets | 8.17M | 9.43M | 11.06M | 7.60M | 832.90K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.40K | 35.40K | 35.40K | 35.40K | 35.40K |
| Total Assets | 8.20M | 9.46M | 11.09M | 7.63M | 868.30K |
|
|
|||||
| Total Accounts Payable | 40.80K | 34.00K | 129.20K | 83.90K | 298.50K |
| Total Accrued Expenses | -- | 80.80K | -- | -- | -- |
| Short-term Debt | -- | -- | 572.90K | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 40.80K | 114.80K | 702.10K | 83.90K | 298.50K |
|
|
|||||
| Total Current Liabilities | 40.80K | 114.80K | 702.10K | 83.90K | 298.50K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 572.90K | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 40.80K | 114.80K | 702.10K | 83.90K | 298.50K |
|
|
|||||
| Common Stock & APIC | 50.10M | 50.08M | 49.97M | 41.15M | 33.03M |
| Retained Earnings | -41.94M | -40.73M | -39.58M | -33.60M | -32.46M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 8.16M | 9.35M | 10.39M | 7.55M | 569.90K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.16M | 9.35M | 10.39M | 7.55M | 569.90K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.16M | 9.35M | 10.39M | 7.55M | 569.90K |
|
|
|||||